ImStar Therapeutics is a biotechnology company developing a breakthrough new approach to treating Amyotrophic Lateral Sclerosis (ALS), or Lou Gehrig's Disease. By exploiting an important new biological target underlying the disease, they hope to make great strides in treating ALS and other related neurodegenerative disorders such as Dementia, Alzheimer's Disease and Parkinson's Disease.
